Stage 0 melanoma typically looks like a flat, irregularly shaped patch of skin with uneven color, often resembling a new or changing freckle, mole, or age spot. Because the abnormal cells are confined entirely to the epidermis (the outermost layer of skin) and haven’t grown deeper, there’s usually no raised bump or lump you can feel. That’s what makes it tricky: it can look deceptively harmless.
How Stage 0 Melanoma Differs From a Normal Mole
The most reliable way to spot a suspicious lesion is the ABCDE framework used by dermatologists. Stage 0 melanoma, also called melanoma in situ, tends to show one or more of these features:
- Asymmetry: One half of the spot doesn’t mirror the other.
- Border irregularity: The edges look ragged, notched, or blurred rather than smooth and round. Pigment may seem to bleed into the surrounding skin.
- Color variation: Instead of one uniform shade, you see a mix of brown, tan, black, or even patches of gray, white, pink, red, or blue within the same spot.
- Diameter: Most melanomas are larger than about 6 millimeters (roughly the size of a pencil eraser), though they can be smaller.
- Evolving: The spot has changed in size, shape, or color over weeks or months.
A normal mole is generally symmetric, evenly colored, and stable over time. Stage 0 melanoma breaks at least one of those rules. The “evolving” criterion is especially important because change over time is often the earliest red flag, even before the spot looks obviously abnormal.
Why It’s Easy to Confuse With an Age Spot
One of the biggest challenges with stage 0 melanoma is that it can closely mimic a solar lentigo, the common brown “age spot” caused by years of sun exposure. Research has shown that distinguishing melanoma in situ from a solar lentigo on sun-damaged skin using appearance alone can be extremely difficult, sometimes virtually impossible without a biopsy and specialized staining techniques. Under a microscope, melanoma in situ has a noticeably higher density of abnormal pigment cells compared to an age spot, but that difference isn’t always visible to the naked eye.
This is why any new, growing, or changing brown spot on sun-exposed skin deserves a closer look, particularly if you’re fair-skinned or have a history of significant sun exposure.
The Lentigo Maligna Subtype
The most common form of stage 0 melanoma on chronically sun-damaged skin is called lentigo maligna. It has a distinctive appearance and growth pattern worth knowing about separately.
Lentigo maligna typically shows up as a slowly expanding, flat, pigmented patch with irregular or ill-defined borders. It strongly favors the head and neck, with the cheeks alone accounting for over half of cases. The patch can appear discontinuous, almost like scattered pigment rather than one solid spot, and in fair-skinned people it sometimes presents as a pale or skin-colored macule rather than a dark one. One unusual early sign on the scalp: previously white or gray hairs in the area may darken as pigment cells proliferate beneath them.
Lentigo maligna grows outward across the skin surface for months to years before it risks becoming invasive. If it eventually develops a raised bump, nodule, or thickened area within the flat patch, that signals the melanoma has started growing deeper and is no longer stage 0.
Where on the Body It Appears
Stage 0 melanoma doesn’t show up randomly. Its location depends on your age, sex, and the specific subtype. Lentigo maligna clusters on the head and neck because those areas accumulate the most lifetime sun damage, and patients with this subtype tend to be older. The superficial spreading type of melanoma in situ, by contrast, can appear on the trunk or limbs and tends to occur in younger patients. Women are diagnosed slightly more often than men, and men tend to be older at diagnosis.
The anatomical distribution of melanoma in situ actually differs from that of invasive melanoma, so a spot in an unexpected location isn’t necessarily reassuring. Any changing pigmented lesion on any part of your body warrants attention.
How It’s Diagnosed
You can’t confirm stage 0 melanoma by appearance alone. A biopsy is required. The preferred method is an excisional biopsy, where the entire suspicious spot is removed and sent to a pathologist. This approach gives the most accurate diagnosis. For melanoma in situ specifically, excisional biopsy and deep shave biopsy both achieve diagnostic accuracy around 73 to 75%, while punch biopsies and superficial shaves drop to roughly 42 to 44%.
For spots that are very large, located on the face, or where melanoma seems unlikely, a partial biopsy (punch or shave) may be used as a first step. Having the sample reviewed by a dermatopathologist, a pathologist who specializes in skin disease, improves accuracy. Under the microscope, the pathologist confirms that abnormal pigment cells are present but confined entirely to the epidermis with no invasion into the deeper dermis layer. That confinement to the surface is what defines the “stage 0” designation.
Treatment and What to Expect
The standard treatment is surgical excision with a margin of healthy skin around the lesion. Current guidelines recommend removing 5 millimeters to 1 centimeter of normal-appearing skin beyond the visible edges of the melanoma. For lentigo maligna on the head and neck, a 5-millimeter margin often turns out to be insufficient because these lesions can have invisible extensions beyond what’s visible on the surface, so wider margins or specialized margin-checking techniques are sometimes needed.
For most people, this is an outpatient procedure done under local anesthesia. The surgeon removes the spot and surrounding margin, the wound is closed with stitches, and the tissue goes to pathology to confirm the edges are clear. Recovery typically involves a healing period of one to several weeks depending on the size and location.
Survival and Recurrence
Stage 0 melanoma has an excellent prognosis. Because the abnormal cells haven’t penetrated beyond the epidermis, they have no access to blood vessels or lymph nodes, which means the risk of spread is essentially zero at this stage. The five-year survival rate for localized melanoma exceeds 99%.
Recurrence after adequate excision is uncommon. A 2025 study in JAMA Dermatology found zero recurrences among patients whose melanoma in situ was removed with even slightly narrower-than-standard margins, followed for a median of over four years. The key is ensuring the pathologist confirms clear margins on the excised tissue. If margins come back positive, meaning abnormal cells extend to the edge of what was removed, a re-excision is typically recommended.
The more meaningful long-term risk isn’t recurrence of the original spot but the development of a new, separate melanoma. Having had one melanoma in situ means your skin has demonstrated it can produce these abnormal cells, so regular full-body skin checks become an important part of ongoing care.